The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2019

Filed:

Apr. 25, 2014
Applicants:

Kabushiki Kaisha Toshiba, Tokyo, JP;

Toshiba Materials Co., Ltd., Yokohama-shi, Kanagawa, JP;

Inventors:

Kayo Nakano, Yokohama, JP;

Akira Sato, Yokohama, JP;

Takao Kusaka, Yokohama, JP;

Shinya Kasamatsu, Yokohama, JP;

Akito Sasaki, Yokohama, JP;

Daisuke Fukushi, Yokohama, JP;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 33/24 (2019.01); B01J 23/30 (2006.01); B01J 35/00 (2006.01); B01J 35/02 (2006.01); B01J 35/10 (2006.01); B01J 37/34 (2006.01); B01J 23/652 (2006.01); B01J 23/888 (2006.01); A01N 25/12 (2006.01); A01N 59/16 (2006.01); A61K 33/38 (2006.01); B01J 23/34 (2006.01); B01J 37/02 (2006.01); B01J 37/04 (2006.01); B01J 35/06 (2006.01); C03C 17/00 (2006.01); B01J 21/06 (2006.01);
U.S. Cl.
CPC ...
A01N 25/12 (2013.01); A01N 59/16 (2013.01); A61K 33/24 (2013.01); A61K 33/38 (2013.01); B01J 23/30 (2013.01); B01J 23/34 (2013.01); B01J 23/6527 (2013.01); B01J 23/888 (2013.01); B01J 35/002 (2013.01); B01J 35/004 (2013.01); B01J 35/023 (2013.01); B01J 35/06 (2013.01); B01J 35/1009 (2013.01); B01J 35/1014 (2013.01); B01J 35/1019 (2013.01); B01J 35/1023 (2013.01); B01J 37/0201 (2013.01); B01J 37/0215 (2013.01); B01J 37/04 (2013.01); B01J 37/349 (2013.01); C03C 17/006 (2013.01); B01J 21/063 (2013.01); B01J 21/066 (2013.01); C03C 2217/42 (2013.01); C03C 2217/70 (2013.01); Y10T 428/2982 (2015.01);
Abstract

In one embodiment, an antiviral material includes at least one microparticles selected from tungsten oxide microparticles and tungsten oxide composite microparticles. The microparticles have an inactivation effect R of 1 or more expressed by [R=log C−log A], when there is evaluated a virus titer by inoculating on a specimen to which the microparticles are adhered, at least one virus selected from a low pathogenic avian influenza virus (H9N2), a high pathogenic avian influenza virus (H5N1) and a swine influenza virus, and irradiating the specimen with visible light having a wavelength of 380 nm or more and illuminance of 6000 lx. for 24 hours.


Find Patent Forward Citations

Loading…